DZ Bank’s Charles River Laboratories CRL Stock Holding History

DZ Bank’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-140	Closed	-$27.6K	–	962
2024 Q3	$27.6K	Hold	140	–	–	﹤0.01%	946
2024 Q2	$28.9K	Hold	140	–	–	﹤0.01%	982
2024 Q1	$37.9K	Hold	140	–	–	﹤0.01%	986
2023 Q4	$33.1K	Hold	140	–	–	﹤0.01%	960
2023 Q3	$27.4K	Hold	140	–	–	﹤0.01%	953
2023 Q2	$29.4K	Hold	140	–	–	﹤0.01%	964
2023 Q1	$28.3K	Sell	140 -37,591	-100%	-$8.52M	﹤0.01%	988
2022 Q4	$8.22M	Buy	37,731 +37,591	+26,851%	+$8.21M	0.01%	381
2022 Q3	$27.6K	Hold	140	–	–	﹤0.01%	981
2022 Q2	$30K	Sell	140 -280	-67%	-$68.4K	﹤0.01%	980
2022 Q1	$119K	Sell	420 -420	-50%	-$130K	﹤0.01%	907
2021 Q4	$316K	Buy	840 +420	+100%	+$163K	﹤0.01%	930
2021 Q3	$173K	Hold	420	–	–	﹤0.01%	854
2021 Q2	$155K	Hold	420	–	–	﹤0.01%	850
2021 Q1	$122K	Hold	420	–	–	﹤0.01%	822
2020 Q4	$104K	Hold	420	–	–	﹤0.01%	804
2020 Q3	$95.1K	Buy	+420	New	+$87.2K	﹤0.01%	751
2019 Q1	–	Sell	-6,000	Closed	-$670K	–	756
2018 Q4	$670K	Buy	+6,000	New	+$751K	﹤0.01%	550

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return

Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

DZ Bank's CRL Position: Q4 2024 in Review

DZ Bank sold out of Charles River Laboratories (CRL) in Q4 2024, closing a stake of 140 shares — an estimated $27.6K sold.

DZ Bank first reported a position in CRL in Q4 2018 and held it in 18 quarters. The position peaked at $8.22M in Q4 2022. 637 funds tracked by Wall St. Rank hold CRL as of Q4 2024.

DZ Bank reported no remaining Charles River Laboratories position as of Q4 2024 after selling out during the quarter.
DZ Bank sold 140 Charles River Laboratories shares in Q4 2024, an estimated $27.6K.
DZ Bank first reported a position in Charles River Laboratories in Q4 2018 and held it in 18 quarters.
DZ Bank's Charles River Laboratories position peaked at $8.22M in Q4 2022.
637 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2024.

Based on DZ Bank's 13F filing for Q4 2024, filed 14 Feb 2025.